(R)-(+)-Etomoxir sodium salt
Tocris Bioscience | Catalog # 4539
Key Product Details
Description
Product Description
(R)-(+)-Etomoxir sodium salt is an inhibitor of carnitine palmitoyltransferase I (CPT1); inhibits β-oxidation in mitochondria. Shown to inhibit cardiolipin biosynthesis from exogenous fatty acid in H9c2 cells.
Product Specifications for (R)-(+)-Etomoxir sodium salt
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 6.41 | 20 | |
| DMSO | 6.41 | 20 with gentle warming |
Preparing Stock Solutions for (R)-(+)-Etomoxir sodium salt
The following data is based on the product molecular weight 320.74.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 15.59 mL | 77.94 mL | 155.89 mL |
| 1 mM | 3.12 mL | 15.59 mL | 31.18 mL |
| 2 mM | 1.56 mL | 7.79 mL | 15.59 mL |
| 10 mM | 0.31 mL | 1.56 mL | 3.12 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 26 publications citing the usage of this product.
- Agius Stereospecificity of the inhibition of etomoxir of fatty acid and cholesterol synthesis in isolated rat hepatocytes. Biochem.Pharmacol. 1991 PMID: 1930298
- Rupp Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 1992 PMID: 1531968
- Xu Etomoxir mediates differential metabolic channeling of fatty acid and glycerol precursors into cardiolipin in H9c2 cells. J.Lipid Res. 2003 PMID: 12576524
Product Documents for (R)-(+)-Etomoxir sodium salt
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for (R)-(+)-Etomoxir sodium salt
For research use only
Citations for (R)-(+)-Etomoxir sodium salt
Customer Reviews for (R)-(+)-Etomoxir sodium salt (4)
Have you used (R)-(+)-Etomoxir sodium salt?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroCell Line/Tissue: MCF7Verified Customer | Posted 03/27/2020MCF7 cells were pretreated with or without 25, 50 μmol/L Etomoxir for 24 h.
-
Species: HumanAssay Type: In VitroCell Line/Tissue: 293TVerified Customer | Posted 01/27/2020Etomoxir shows good solubility profile when diluted from 20 mM stock in DMSO. Does not cause cell death across cell lines at 20 uM.Product was diluted to 20 uM in tissue culture and various cancer cells were treated for 18-30 h at this concentration. Enzyme activity was measured by flow cytometry after. Results were strongly replicable.
-
Assay Type: In VitroVerified Customer | Posted 10/05/2018Etomoxir was used as a CPT1 inhibitor in endothelial cells. The data was shown in the publication PubMed ID 29429925.
-
Species: MouseAssay Type: Ex VivoCell Line/Tissue: acute brain sliceVerified Customer | Posted 01/04/2018Pre-incubation of 15 minutes at 100 uMExogenous application on acute brain slices
There are no reviews that match your criteria.